XENICAL

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug XENICAL contains one active pharmaceutical ingredient (API):

1 Orlistat
UNII 95M8R751W8 - ORLISTAT

Orlistat is a potent, specific and long-acting inhibitor of gastrointestinal lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine site of the gastric and pancreatic lipases. The inactivated enzyme is thus unavailable to hydrolyse dietary fat, in the form of triglycerides, into absorbable free fatty acids and monoglycerides.

Read about Orlistat

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XENICAL Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
XENICAL Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A08AB01 Orlistat A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AB Peripherally acting antiobesity products
Discover more medicines within A08AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 4570M
Country: CA Health Products and Food Branch Identifier(s): 02240325
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 4903-MEE-1219
Country: EE Ravimiamet Identifier(s): 1042388, 1063684, 1063695, 1888342
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 98071002IP, 98071003, 98071003IP, 98071003IP1, 98071003IP3, 98071003IP4, 98071003IP5, 98071003IP6, 98071003IP7
Country: FR Base de données publique des médicaments Identifier(s): 65715632
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 19237, 381763
Country: HK Department of Health Drug Office Identifier(s): 44752
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4166
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1014357, 1031407, 1031408, 1031409, 1031410, 1031411
Country: NL Z-Index G-Standaard, PRK Identifier(s): 51535
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7932
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100237124
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63610001, W63610002
Country: SG Health Sciences Authority Identifier(s): 13046P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8682340179046
Country: US FDA, National Drug Code Identifier(s): 61269-460
Country: ZA Health Products Regulatory Authority Identifier(s): 32/11.3.1/0475

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.